These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17363113)

  • 1. Striatal dopamine transporters correlate with simple reaction time in elderly subjects.
    van Dyck CH; Avery RA; MacAvoy MG; Marek KL; Quinlan DM; Baldwin RM; Seibyl JP; Innis RB; Arnsten AF
    Neurobiol Aging; 2008 Aug; 29(8):1237-46. PubMed ID: 17363113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene.
    van Dyck CH; Malison RT; Jacobsen LK; Seibyl JP; Staley JK; Laruelle M; Baldwin RM; Innis RB; Gelernter J
    J Nucl Med; 2005 May; 46(5):745-51. PubMed ID: 15872345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal dopamine transporter availability with [123I]beta-CIT SPECT is unrelated to gender or menstrual cycle.
    Best SE; Sarrel PM; Malison RT; Laruelle M; Zoghbi SS; Baldwin RM; Seibyl JP; Innis RB; van Dyck CH
    Psychopharmacology (Berl); 2005 Dec; 183(2):181-9. PubMed ID: 16175405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No correlation between body mass index and striatal dopamine transporter availability in healthy volunteers using SPECT and [123I]PE2I.
    Thomsen G; Ziebell M; Jensen PS; da Cuhna-Bang S; Knudsen GM; Pinborg LH
    Obesity (Silver Spring); 2013 Sep; 21(9):1803-6. PubMed ID: 23696269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3.
    van de Giessen E; de Win MM; Tanck MW; van den Brink W; Baas F; Booij J
    J Nucl Med; 2009 Jan; 50(1):45-52. PubMed ID: 19091889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association between striatal dopamine transporter binding and body mass index: a multi-center European study in healthy volunteers.
    van de Giessen E; Hesse S; Caan MW; Zientek F; Dickson JC; Tossici-Bolt L; Sera T; Asenbaum S; Guignard R; Akdemir UO; Knudsen GM; Nobili F; Pagani M; Vander Borght T; Van Laere K; Varrone A; Tatsch K; Booij J; Sabri O
    Neuroimage; 2013 Jan; 64():61-7. PubMed ID: 22982354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal dopamine transporter binding correlates with serum BDNF levels in patients with striatal dopaminergic neurodegeneration.
    Ziebell M; Khalid U; Klein AB; Aznar S; Thomsen G; Jensen P; Knudsen GM
    Neurobiol Aging; 2012 Feb; 33(2):428.e1-5. PubMed ID: 21176997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts.
    Kraemmer J; Kovacs GG; Perju-Dumbrava L; Pirker S; Traub-Weidinger T; Pirker W
    Mov Disord; 2014 Dec; 29(14):1767-73. PubMed ID: 25048738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogen regulates the expression and function of dopamine transporters in astrocytes of the nigrostriatal system.
    Karakaya S; Kipp M; Beyer C
    J Neuroendocrinol; 2007 Sep; 19(9):682-90. PubMed ID: 17680883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular imaging of striatal dopamine transporters in major depression--a meta-analysis.
    Li Z; He Y; Tang J; Zong X; Hu M; Chen X
    J Affect Disord; 2015 Mar; 174():137-43. PubMed ID: 25497470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related changes in nigrostriatal dopaminergic function in heterozygous mutant dopamine transporter knock-out mice.
    Dluzen DE; Ji J; McDermott JL
    Neurosci Lett; 2010 May; 476(2):66-9. PubMed ID: 20382201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac repolarization and striatal dopamine transporter function are interrelated.
    Kauppila E; Vanninen E; Kuusela T; Kaurijoki S; Karhunen L; Pietiläinen KH; Rissanen A; Kaprio J; Tiihonen J; Kuikka J
    Nucl Med Commun; 2009 Sep; 30(9):713-7. PubMed ID: 19550362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dedifferentiation of caudate functional connectivity and striatal dopamine transporter density predict memory change in normal aging.
    Rieckmann A; Johnson KA; Sperling RA; Buckner RL; Hedden T
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10160-10165. PubMed ID: 30224467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between errors on the Wisconsin Card Sorting Test and the availability of striatal dopamine transporters in healthy volunteers.
    Hsieh PC; Yeh TL; Lee IH; Huang HC; Chen PS; Yang YK; Chiu NT; Lu RB; Liao MH
    J Psychiatry Neurosci; 2010 Mar; 35(2):90-4. PubMed ID: 20184806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in nigrostriatal dopaminergic innervation are present at young-to-middle but not at older age in normal adults.
    Wong KK; Müller ML; Kuwabara H; Studenski SA; Bohnen NI
    J Clin Neurosci; 2012 Jan; 19(1):183-4. PubMed ID: 22030267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional implications of changes in the senescent brain: a review.
    Beck CH
    Can J Neurol Sci; 1978 Nov; 5(4):417-24. PubMed ID: 33759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: The association of DAT gene methylation with striatal DAT availability in healthy subjects.
    Pak K; Seok JW; Nam HY; Seo S; Lee MJ; Kim K; Kim IJ
    EJNMMI Res; 2023 May; 13(1):41. PubMed ID: 37162612
    [No Abstract]   [Full Text] [Related]  

  • 18. Correction: No association of Brain-derived neurotrophic factor with striatal dopamine transporter availability in healthy subjects.
    Nam HY; Seo S; Lee MJ; Kim K; Kim IJ; Pak K
    Nuklearmedizin; 2023 Jun; ():. PubMed ID: 37315928
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical assessment and striatal dopaminergic activity in healthy controls and patients with Parkinson's disease: a Bayesian approach.
    Shin S; Nam HY; Kim K; Kim J; Lee MJ; Pak K
    Ann Nucl Med; 2024 Dec; 38(12):989-998. PubMed ID: 39190111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slowing of Movements in Healthy Aging as a Rational Economic Response to an Elevated Effort Landscape.
    Summerside EM; Courter RJ; Shadmehr R; Ahmed AA
    J Neurosci; 2024 Apr; 44(15):. PubMed ID: 38408872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.